Cardiac Biomarkers Market: By Biomarker Type, Ischemia Modified Albumin, Creatine Kinase, Myoglobin, Troponins, and Others), By Disease Type, By End User, and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Cardiac Biomarkers Market Size, Share, Growth, Trends, and Global Industry Analysis: By Biomarker Type (Natriuretic Peptides (BNP And NT-ProBNP), Ischemia Modified Albumin, Creatine Kinase, Myoglobin, Troponins (T,I), and Others), By Disease Type (Acute Coronary Syndrome, Congestive Heart Failure, Atherosclerosis, Myocardial Infarction, and Others), By End User (Laboratory Testing, Point of Care Testing), and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Cardiac Biomarkers Market size was valued at US$ 13.08 billion in 2023 and is expected to reach US$ 25.08 billion by 2030, at a CAGR of 10.08% from 2024-2030. Cardiac biomarkers are the substances that usually released into the blood when the heart is stressed or damaged. They are helpful in the diagnosis of an acute coronary syndrome (ACS) and cardiac ischemia, and other conditions associated with insufficient blood flow to the heart. The test for cardiac biomarkers is used to determine an individuals risk of having the above conditions. A cardiac biomarker is a protein-based molecule that may be quantified for heart disease prognosis and diagnosis. When the heart is injured or stressed, such as from a lack of oxygen, cardiac biomarkers are released into the bloodstream. Cardiovascular biomarkers including cardiac troponin, creatinine kinase, myoglobin, and others are used to diagnose disorders like ACS and heart ischemia.

summary download arrow Download Free Sample

Cardiac Biomarkers Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

10%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Cardiac Biomarkers Market Dynamics

Increase in the prevalence of cardiovascular diseases anticipated to drive the growth of the market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) take the lives of 17.7 million people every year, 31% of all global deaths. Growing awareness among the people regarding the early diagnosis of the disease is expected to fuel the market. The factors such as highly accurate results and point of care testing are driving the growth of the market. However, the poor reimbursement policies are likely to hamper the growth of the market. The stringent government regulations for test approvals are hindering the growth of the cardiac biomarkers market.

Cardiac Biomarkers Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 13.08 billion

Market Size in 2030

US$ 25.08 billion

Market CAGR

10%

By Biomarker Type

  • Natriuretic Peptides (BNP And NT-ProBNP)
  • Ischemia Modified Albumin
  • Creatine Kinase
  • Myoglobin
  • Troponins (T,I)
  • Others

By Disease Type

  • Acute Coronary Syndrome
  • Congestive Heart Failure
  • Atherosclerosis
  • Myocardial Infarction
  • Others

By End User

  • Laboratory Testing
  • Point of Care Testing

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The cardiac biomarkers market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The cardiac biomarkers market size was valued at US$ 13.08 billion in 2023 and is set to reach US$ 25.08 billion by 2030 at a CAGR of 10% from 2024-2030

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Cardiac Biomarkers Market Introduction 
2.1.Global Cardiac Biomarkers Market  - Taxonomy
2.2.Global Cardiac Biomarkers Market  - Definitions
2.2.1.Biomarker Type
2.2.2.Disease Type
2.2.3.End User
2.2.4.Region
3. Global Cardiac Biomarkers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Cardiac Biomarkers Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Cardiac Biomarkers Market  By Biomarker Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Natriuretic Peptides (BNP And NT-ProBNP)
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Ischemia Modified Albumin
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Creatine Kinase
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Myoglobin
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Troponins (T,I)
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Global Cardiac Biomarkers Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Acute Coronary Syndrome
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Congestive Heart Failure
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Atherosclerosis
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Myocardial Infarction
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Cardiac Biomarkers Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Laboratory Testing
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Point of Care Testing
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8. Global Cardiac Biomarkers Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Cardiac Biomarkers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Biomarker Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Natriuretic Peptides (BNP And NT-ProBNP)
9.1.2.Ischemia Modified Albumin
9.1.3.Creatine Kinase
9.1.4.Myoglobin
9.1.5.Troponins (T,I)
9.1.6.Others
9.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Acute Coronary Syndrome
9.2.2.Congestive Heart Failure
9.2.3.Atherosclerosis
9.2.4.Myocardial Infarction
9.2.5.Others
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Laboratory Testing
9.3.2.Point of Care Testing
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Cardiac Biomarkers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Natriuretic Peptides (BNP And NT-ProBNP)
10.1.2.Ischemia Modified Albumin
10.1.3.Creatine Kinase
10.1.4.Myoglobin
10.1.5.Troponins (T,I)
10.1.6.Others
10.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Acute Coronary Syndrome
10.2.2.Congestive Heart Failure
10.2.3.Atherosclerosis
10.2.4.Myocardial Infarction
10.2.5.Others
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Laboratory Testing
10.3.2.Point of Care Testing
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Cardiac Biomarkers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Natriuretic Peptides (BNP And NT-ProBNP)
11.1.2.Ischemia Modified Albumin
11.1.3.Creatine Kinase
11.1.4.Myoglobin
11.1.5.Troponins (T,I)
11.1.6.Others
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Acute Coronary Syndrome
11.2.2.Congestive Heart Failure
11.2.3.Atherosclerosis
11.2.4.Myocardial Infarction
11.2.5.Others
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Laboratory Testing
11.3.2.Point of Care Testing
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Cardiac Biomarkers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Natriuretic Peptides (BNP And NT-ProBNP)
12.1.2.Ischemia Modified Albumin
12.1.3.Creatine Kinase
12.1.4.Myoglobin
12.1.5.Troponins (T,I)
12.1.6.Others
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Acute Coronary Syndrome
12.2.2.Congestive Heart Failure
12.2.3.Atherosclerosis
12.2.4.Myocardial Infarction
12.2.5.Others
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Laboratory Testing
12.3.2.Point of Care Testing
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Cardiac Biomarkers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Natriuretic Peptides (BNP And NT-ProBNP)
13.1.2.Ischemia Modified Albumin
13.1.3.Creatine Kinase
13.1.4.Myoglobin
13.1.5.Troponins (T,I)
13.1.6.Others
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Acute Coronary Syndrome
13.2.2.Congestive Heart Failure
13.2.3.Atherosclerosis
13.2.4.Myocardial Infarction
13.2.5.Others
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Laboratory Testing
13.3.2.Point of Care Testing
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Randox laboratories (UK)
14.2.2.Thermo Fisher Scientific (U.S)
14.2.3.Roche Diagnostics (Switzerland)
14.2.4.Abbott Laboratories (U.S)
14.2.5.Siemens Healthcare (Germany)
14.2.6.Alere Inc. (U.S)
14.2.7.Becton, Dickinson and Company (U.S)
14.2.8.Bio-Rad Laboratories (U.S)
14.2.9.BioMerieux (France)
14.2.10.Beckman Coulter (U.S)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Randox laboratories (UK)
  • Thermo Fisher Scientific (U.S)
  • Roche Diagnostics (Switzerland)
  • Abbott Laboratories (U.S)
  • Siemens Healthcare (Germany)
  • Alere Inc. (U.S)
  • Becton, Dickinson and Company (U.S)
  • Bio-Rad Laboratories (U.S)
  • BioMerieux (France)
  • Beckman Coulter (U.S)

Related Industry Reports

Cardiac Ablation Systems Market

Cardiac Assist Devices Market

Cardiac Resynchronization Therapy Market

Global Cardiac Guide Wire Catheters Market